肝纤维化的基因治疗现状

陈莎燕; 曾令兰

肝纤维化的基因治疗现状

详细信息

中图分类号: R575.2
计量
- 文章访问数: 3401
- HTML全文浏览量: 2
- PDF下载量: 1012
- 被引次数: 10
出版历程
- 出版日期: 2007-05-20

摘要

HTML全文

参考文献(15)

[1]Song YH, Chen XL, Kong XL, et al.Ribozymes against TGF beta 1reverse character of activated hepatic stellate cells in vitro and inhibitliver fibrosis in rats[J].Ournal of Gene Medicine, 2005, 7 (7) ∶965-976.

[2]Qi Z, Atsuchi N, Ooshima A, et al.Blockade of type beta transfor-ming growth factor si gnaling preventing liver fibrosis and dysfunctionin the rat[J].Proc Natl Acad Sci, 1999, 96∶2345-2349.

[3]Inagaki Y, Kushida M, Higashi K, et al.Cell type-specific inter-vention of transforming growth factor beta/smad signaling supressescollagen gene expression and hepatic fibrosis in mice[J].Gastroen-terology, 2005, 129 (1) ∶295-68.

[4]Suzuki K, Aoki K, Ohnami S, et al.Adenovirus-mediated genetransfer of interferon alpha improves dimethylnitrosamine-inducedliver cirrhosis in rat model[J].Gene Ther, 2003∶765-773.

[5]Xia JI, Dai C, Michalopoulos GK, et al.Hepatocyte growth factorattenuates liver fibrosis induced by bile duct ligation[J].Am JPathol, 2006, 168 (5) ∶1500-12.

[6]Xue F, Takahara T, Yata Y, et al.Hepatocyte growth factor genetherapy accelerates regen eration in cirrhotic mouse livers after hepatectomy[J].Gut, 2003, 52∶694-700.

[7]Iimuro Y, Nishio T, Morimoto T, et al.Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat[J].Gastroenterology, 2003, 124∶445-458.

[8]Siller-Lopen F, Sandoval A, Salgado S, et al.Treatment With Hu-man Metalloproteinase-8 Gene Delivery Ameliorates ExperimentalRat Liver Cirrhosis[J].Gastroenterology, 2004, 126∶1122-1133.

[9]Zhang LH, Pan JP, Yao HP, et al.Intrasplenic transplantation of IL-18 gene-modified hepatocytes:an effective approach to reversehepatic fibrosis in schistosomiasis through induction of dominant Th1response[J].Gene Ther, 2001, 8∶1333-1342.

[10]Wang CH, Lee TH, Lu CN, et al.Eletroporative alpha-MSHgene transfer attenuates thioacetamide-induced murine hepatic fi-brosis by MMP and TIMP modulation[J].Gene Ther, 2006, 13 (13) ∶1000-9.

[11]Miranda-Diaz A, Rincon AR, Salgado S, et al.Improved effectsof viral gene delivery of human uPA plus biliodigestive anastomosisinduce recovery from experimentalbiliary cirrhosis[J].Mol Ther, 2004, 9∶30-37.

[12]Rudolph KL, Chang S, Millard M, et al.Inhibition of experimentalliver cirrhosis in mice by telomerase gene delivery[J].Science, 2000, 287∶1253-1258.

[13]Tsui TY, Lau CK, Ma J, et al.Raav-mediated stable expressionof heme oxygenase-1 in stellates:a new approach to attenuate liverfibrosis in rats[J].Hepatology, 2005, 42 (2) ∶335-42.

[14]Chen C, Zhang J, Li J, et al.Hydrodynamic-based in vivo trans-fection of retinoic X receptor-alpha gene can enhance vitamin A-induced attenuation of liver fibrosis in mice[J].Internist (Berl) , 2005, 46 (7) ∶731-2, 734-6, 738-40.

[15]Zhong Z, Froh M, Wheeler MD, et al.Viral gene delivery of su-peroxide dismutase attenuates experimental cholestasis-induced liverfibrosis in the rat[J].Gene Ther, 2002, 9∶183-191.

施引文献

期刊类型引用(8)

1.	石文静，彭杰，张涛，伍玉南，陈斌. 鳖龙软肝片联合抗病毒药治疗乙型肝炎肝硬化的回顾性临床研究. 湖南中医药大学学报. 2024(03): 473-478 . 百度学术
2.	曹海丹，罗晓蓉，吴县斌. 肝纤维化指标、TIMP-1在慢性乙型肝炎纤维化中的诊断效能及与肝硬化的关联性分析. 重庆医学. 2021(06): 991-995 . 百度学术
3.	陈小莉，栗文杰，赵俊彪，张智勤. 疏肝健脾方联合恩替卡韦治疗慢性乙型肝炎肝郁脾虚证临床研究. 新中医. 2020(07): 77-79 . 百度学术
4.	梁彦玲. 扶正化瘀胶囊配合常规西药治疗肝纤维化48例. 河南中医. 2019(04): 579-582 . 百度学术
5.	文政伟，李秋兰，何均辉. 慢性乙型肝炎患者抗病毒治疗后肝纤维化动态变化的定性评估. 中国肝脏病杂志(电子版). 2019(01): 77-80 . 百度学术
6.	刘军城，庄慧雁. 中药分期序贯方案对慢性乙型肝炎肝纤维化逆转和补体C3影响的研究. 云南中医中药杂志. 2019(08): 21-23 . 百度学术
7.	徐晓义，夏树伟，黄小俊，潘艳. 慢性乙型肝炎患者病情严重程度与血清钙水平的关系. 中国实验诊断学. 2019(11): 1929-1931 . 百度学术
8.	杨杰文，洪浚娜，方佳，薛峰，金伟勋. 白介素-22和肝纤四项检测对肝纤维化程度的诊断价值. 中国当代医药. 2018(27): 123-125+135 . 百度学术